Monday, July 10, 2023 9:16:29 AM
Smokey, Biosect is a genius; I am here because of posters like Biosect, ATL, Doc Logic, Crash, hoffman, pqr, flipper, horseb4cart and so on. These HyCrows are simply crowing the post hoc this and that same dame thing over and over while the FDA is releasing guidance saying 'post hoc' is ok and 'adaptive trial' is ok. And biosect is saying the 'combo immunotherapy' is coming in the form of cell therapies like DcVaxL and we all know DcVaxL can't be beaten down at any time into the future as the lysate science brings the best vaccine therapy possible. Look REGN is saying what biosect is saying. We know who is behind REGN? Kevin Duffy. See the reference list put together that carefully avoids our JAMA paper. But no matter what REGN is attempting to put into their cocktail, DcVaxL is indispensable for the combo concept to work best; I bet Kevin knows that.
https://endpts.com/sp/immuno-oncology-2-0-how-regeneron-is-utilizing-its-expertise-in-antibodies-to-lead-the-next-wave-of-combinatorial-approaches-in-cancer-care/
https://endpts.com/sp/immuno-oncology-2-0-how-regeneron-is-utilizing-its-expertise-in-antibodies-to-lead-the-next-wave-of-combinatorial-approaches-in-cancer-care/
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
